Salt Restriction for Dialysis Patients Blood Pressure
Author: American Society of Nephrology
Published: 2010/05/29 - Updated: 2026/02/13
Publication Type: Research, Study, Analysis
Category Topic: Hypertension - Related Publications
Contents: Synopsis - Introduction - Main - Insights, Updates
Synopsis: This research published in the Clinical Journal of the American Society of Nephrology presents peer-reviewed findings from Indiana University School of Medicine and University of Maryland Medical Center demonstrating that dialysis patients can better control hypertension through dietary sodium restriction and dry-weight management rather than relying primarily on blood pressure medications. The analysis provides practical, evidence-based guidance for the millions of Americans with chronic kidney disease who face elevated cardiovascular mortality risks. Patients with kidney disease often struggle with fluid retention between dialysis sessions, and these findings offer a medication-light approach that addresses the root cause of blood pressure elevation while reducing treatment complexity for individuals managing multiple chronic conditions - Disabled World (DW).
- Definition: Dry Weight (Kidneys)
Dry-weight, in the context of kidney disease and dialysis, refers to a patient's target weight when all excess fluid has been removed from the body - essentially what someone should weigh when they're neither fluid-overloaded nor dehydrated. For people with kidney failure, the kidneys can't regulate fluid balance properly, so fluid accumulates between dialysis sessions, leading to swelling, high blood pressure, and strain on the heart. Determining the right dry-weight is more art than science; nephrologists adjust it based on blood pressure trends, physical examination for edema, and sometimes more objective measures like bioimpedance or imaging of the inferior vena cava. It's not a fixed number - it changes with actual weight gain or loss from muscle or fat - and getting it wrong in either direction causes problems: set it too low and patients become hypotensive and crampy during dialysis; set it too high and they walk around chronically volume-overloaded, which damages the cardiovascular system over time. Achieving and maintaining an accurate dry-weight is one of the most important but challenging aspects of managing dialysis patients, requiring constant clinical reassessment and fine-tuning.
Introduction
Cut the Salt and Ditch the Drugs
For kidney patients trying to control their blood pressure, reducing fluid build-up in the blood is more effective than using antihypertensive medications, according to an analysis appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology ( CJASN ). The research suggests that lowering salt intake may help reduce build-up.
Dry-weight is a kidney disease patient's weight immediately after dialysis, when he or she does not carry the excess fluid that builds up between dialysis treatments. Dry-weight is the lowest weight one can safely reach after dialysis without developing symptoms of low blood pressure such as cramping, which can occur when too much fluid is removed. If a patient lets too much fluid build up between sessions, it is harder to get down to a proper dry-weight. Achieving and maintaining dry-weight can improve blood pressure between dialysis sessions and limit hospitalizations. This appears to be an effective but forgotten strategy in controlling and maintaining blood pressure control among hypertensive patients on dialysis.
Rajiv Agarwal, MD (Indiana University School of Medicine and Roudebush VA Medical Center) and Matthew Weir, MD (University of Maryland Medical Center) looked to see what information is available in the medical literature related to dry-weight and its use in achieving blood pressure control. Their goal was to provide an overview of the concept of dry-weight: how to assess it and how to achieve it.
Main Content
The investigators found that dry-weight can be assessed inexpensively through relative plasma volume monitoring (which uses photo-optical technology to assess changes in volume of a patient's blood) and body impedance analysis (which determines lean body mass). They also discovered that restricting salt intake can help control blood pressure and make it easier for patients to get down to a proper dry-weight. Studies suggest that salt restriction and dry-weight reduction through dialysis together provide more benefits to the heart than antihypertensive medications. This could have important clinical implications because most patients with chronic kidney disease die from cardiovascular causes.
The authors concluded that "medication-directed approaches for blood pressure control should be a secondary consideration to manipulating the diet and dialysis prescription in order to achieve dry-weight."
Reducing salt intake is getting easier now that many restaurants and packaged food companies are participating in the National Salt Reduction Initiative, a public-private partnership formed to combat America's over-consumption of salt. Their goal is to reduce sodium in their products by 20% over the next five years. Also, the U.S. Food and Drug Administration is planning to launch an initiative later this year to reduce Americans' salt intake by imposing legal limits on the amount of sodium allowed in processed food.
The article, entitled "Dry-Weight: A Concept Revisited in an Effort to Avoid Medication-Directed Approaches for Blood Pressure Control in Hemodialysis Patients," will appear online on May 27, 2010.
Founded in 1966, the American Society of Nephrology (ASN) is the world's largest professional society devoted to the study of kidney disease. Comprised of 11,000 physicians and scientists, ASN continues to promote expert patient care, to advance medical research, and to educate the renal community. ASN also informs policymakers about issues of importance to kidney doctors and their patients. ASN funds research, and through its world-renowned meetings and first-class publications, disseminates information and educational tools that empower physicians.
Insights, Analysis, and Developments
Editorial Note: The implications of prioritizing salt restriction and fluid management over pharmaceutical interventions represent a significant shift in thinking about blood pressure control for dialysis patients. Given that cardiovascular disease remains the leading cause of death among those with chronic kidney disease, these findings suggest that what patients eat - or more precisely, what they avoid - may matter more than what they take from a pill bottle. As food manufacturers gradually reduce sodium content in processed foods through initiatives like the National Salt Reduction Initiative, kidney patients may find it increasingly easier to implement these dietary changes. The real challenge lies in changing clinical practice patterns to emphasize dry-weight achievement and sodium restriction as first-line interventions, with antihypertensive medications serving as secondary support when needed - Disabled World (DW).Attribution/Source(s): This quality-reviewed publication was selected for publishing by the editors of Disabled World (DW) due to its relevance to the disability community. Originally authored by American Society of Nephrology and published on 2010/05/29, this content may have been edited for style, clarity, or brevity.